In the current study, we tested the hypothesis that sinomenine may enhance the sensitivity of cancer cells towards antitumor drugs and investigated the potential molecular mechanisms of this effect by directly assessing the effect of COX-2 and NF-κB pathways on P-gp expression. The gene discussed is PGP; the disease is cancer.